R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers. 1994

R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
Division of Hypertension and Vascular Medicine, Massachusetts General Hospital, Boston 02114.

The hemodynamic and humoral effects of the specific human renin inhibitor R-PEP-27 were studied in six normal human subjects on low and high sodium intake diets. An intravenous infusion of R-PEP-27 (0.5 to 16 micrograms/min/kg body wt) reduced blood pressure in a dose-dependent fashion; the mean arterial blood pressure at the end of the infusion fell from 128 +/- 4/83 +/- 4 to 119 +/- 3/71 +/- 3 mm Hg (mean +/- SEM) (P < .01) during the low sodium intake diet. R-PEP-27 had no effect on blood pressure during the high sodium intake diet. R-PEP-27 significantly reduced plasma angiotensin II and aldosterone concentrations. The temporal response to R-PEP-27 suggests that it is a short-lived although highly potent competitive inhibitor of renin; this peptide is a valuable and specific physiologic probe of the renin-angiotensin system.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
May 1993, Hypertension (Dallas, Tex. : 1979),
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
January 1971, Experientia,
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
May 2000, The Journal of biological chemistry,
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
December 1981, Clinical science (London, England : 1979),
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
June 1975, Clinical science and molecular medicine. Supplement,
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
March 1977, Kidney international,
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
April 1972, Clinical science,
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
January 1975, The Journal of clinical endocrinology and metabolism,
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
October 1990, Clinical science (London, England : 1979),
R M Zusman, and K Y Hui, and J Nussberger, and D M Christensen, and J Higgins, and W D Carlson, and D Schoenfeld, and E Haber
December 1976, Clinical science and molecular medicine. Supplement,
Copied contents to your clipboard!